Epidemiology of invasive cutaneous melanoma

Data are presented on the current incidence of melanoma with recent and predicted future trends illustrating a likely continuing increase in incidence. Risk factors for developing melanoma are discussed, including current known melanoma susceptibility genes. Phenotypic markers of high-risk subjects include high counts of benign melanocytic naevi. Other risk factors considered include exposure to natural and artificial ultraviolet radiation, the effect of female sex hormones, socioeconomic status, occupation, exposure to pesticides and ingestion of therapeutic drugs including immunosuppressives and non-steroidal anti-inflammatory drugs. Aids to earlier diagnosis are considered, including public education, screening and use of equipment such as the dermatoscope. Finally, the current pattern of survival and mortality is described.

[1]  M. Garmyn,et al.  Melanoma screening: results of the first one‐day campaign in Belgium (‘Melanoma Monday’) , 2000, Journal of the European Academy of Dermatology and Venereology : JEADV.

[2]  M. Haniffa,et al.  The use of a spectrophotometric intracutaneous analysis device in the real‐time diagnosis of melanoma in the setting of a melanoma screening clinic , 2007, The British journal of dermatology.

[3]  G. Colditz,et al.  Risk Factors for Melanoma by Body Site , 2005, Cancer Epidemiology Biomarkers & Prevention.

[4]  F. Grange Épidémiologie du mélanome cutané : données descriptives en France et en Europe , 2005 .

[5]  A. Auvinen,et al.  Incidence of cancer among Nordic airline pilots over five decades: occupational cohort study , 2002, BMJ : British Medical Journal.

[6]  R. Millikan,et al.  Number of Nevi and Early-Life Ambient UV Exposure Are Associated with BRAF-Mutant Melanoma , 2007, Cancer Epidemiology Biomarkers & Prevention.

[7]  A. Halpern,et al.  Reproductive risk factors for cutaneous melanoma in women: a case-control study. , 2006, American journal of epidemiology.

[8]  C. Hollenbeak,et al.  Increased incidence of melanoma in renal transplantation recipients , 2005, Cancer.

[9]  Horton,et al.  Annals of Oncology , 1991, Springer US.

[10]  J. Ferlay,et al.  Cancer Incidence in Five Continents , 1970, Union Internationale Contre Le Cancer / International Union against Cancer.

[11]  J. Aitken,et al.  A randomised trial of population screening for melanoma , 2002, Journal of medical screening.

[12]  J. Grob,et al.  The 'ugly duckling' sign: identification of the common characteristics of nevi in an individual as a basis for melanoma screening. , 1998, Archives of dermatology.

[13]  S. Leachman,et al.  Melanoma genetics: a review of genetic factors and clinical phenotypes in familial melanoma , 2006, Current opinion in oncology.

[14]  E. White,et al.  Melanoma risk by age and socio‐economic status , 1990, International journal of cancer.

[15]  St,et al.  Epidemiology and cancer registries in the Pacific Basin , 1977 .

[16]  C. Garbe,et al.  Improvement of overall survival of patients with cutaneous melanoma in Germany, 1976–2001 , 2007, Cancer.

[17]  F. D. de Gruijl,et al.  Predictions of skin cancer incidence in the Netherlands up to 2015 , 2005, The British journal of dermatology.

[18]  R. MacKie,et al.  Audit of public education campaign to encourage earlier detection of malignant melanoma. , 1992, BMJ.

[19]  Nils Homer,et al.  Common sequence variants on 20q11.22 confer melanoma susceptibility , 2008, Nature Genetics.

[20]  Sabine Siesling,et al.  Recent trends of cancer in Europe: a combined approach of incidence, survival and mortality for 17 cancer sites since the 1990s. , 2008, European journal of cancer.

[21]  M. Nicolson,et al.  Melanoma incidence and mortality in Scotland 1979–2003 , 2007, British Journal of Cancer.

[22]  F. Grange [Epidemiology of cutaneous melanoma: descriptive data in France and Europe]. , 2005, Annales de dermatologie et de venereologie.

[23]  S. Rosso,et al.  Pregnancy History and Incidence of Melanoma in Women: A Pooled Analysis , 2006, Cancer Causes & Control.

[24]  F. Wojnarowska,et al.  Melanomas in renal transplant recipients , 2006, The British journal of dermatology.

[25]  B. Armstrong,et al.  Epidemiology of pre‐invasive and invasive malignant melanoma in Western Australia , 1980, International journal of cancer.

[26]  S. Varma,et al.  Audit of a melanoma screening day in the U.K.: clinical results, participant satisfaction and perceived value , 2001, The British journal of dermatology.

[27]  M. Janssen-Heijnen,et al.  Superior survival of females among 10,538 Dutch melanoma patients is independent of Breslow thickness, histologic type and tumor site. , 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

[28]  H. Dal,et al.  Does relative melanoma distribution by body site 1960-2004 reflect changes in intermittent exposure and intentional tanning in the Swedish population? , 2007, European journal of dermatology : EJD.

[29]  F. Sera,et al.  MC1R variants, melanoma and red hair color phenotype: A meta‐analysis , 2008, International journal of cancer.

[30]  D. Whiteman,et al.  A Risk Prediction Tool for Melanoma? , 2005, Cancer Epidemiology Biomarkers & Prevention.

[31]  D. Duffy,et al.  MC1R genotype modifies risk of melanoma in families segregating CDKN2A mutations. , 2001, American journal of human genetics.

[32]  The association of use of sunbeds with cutaneous malignant melanoma and other skin cancers: A systematic review , 2007, International journal of cancer.

[33]  J. Aitken,et al.  Increase in skin cancer screening during a community‐based randomized intervention trial , 2006, International journal of cancer.

[34]  C. J. O'doherty,et al.  Benign melanocytic naevi as a risk factor for malignant melanoma. , 1986, British medical journal.

[35]  J. Coebergh,et al.  Cutaneous malignant melanoma in Europe. , 2004, European journal of cancer.

[36]  B. Armstrong,et al.  Trends in the incidence of cutaneous malignant melanoma in New South Wales, 1983–1996 , 2001, International journal of cancer.

[37]  R. Herings,et al.  Is statin use associated with a reduced incidence, a reduced Breslow thickness or delayed metastasis of melanoma of the skin? , 2007, European journal of cancer.

[38]  H. Storm,et al.  Radiation-induced acute myeloid leukaemia and other cancers in commercial jet cockpit crew: a population-based cohort study , 1999, The Lancet.

[39]  H. Kittler,et al.  Diagnostic accuracy of dermoscopy. , 2002, The Lancet. Oncology.

[40]  B. Diffey,et al.  The future incidence of cutaneous melanoma within the U.K. , 2004, The British journal of dermatology.

[41]  R. Gallagher,et al.  Body site distribution of cutaneous malignant melanoma in relationship to patterns of sun exposure , 1998, International journal of cancer.

[42]  R. MacKie,et al.  Reasons for poor prognosis in British patients with cutaneous malignant melanoma. , 1986, British medical journal.

[43]  Kari Stefansson,et al.  ASIP and TYR pigmentation variants associate with cutaneous melanoma and basal cell carcinoma , 2008, Nature Genetics.

[44]  Donald R. Miller,et al.  The first 15 years of the American Academy of Dermatology skin cancer screening programs: 1985-1999. , 2003, Journal of the American Academy of Dermatology.

[45]  R. Stern,et al.  Incidence of skin cancer in 5356 patients following organ transplantation , 2000, The British journal of dermatology.

[46]  C. Ingvar,et al.  Invasive cutaneous malignant melanoma in Sweden, 1990–1999 , 2004, Cancer.

[47]  Westgate Road,et al.  The use of a spectrophotometric intracutaneous analysis device in the real-time diagnosis of melanoma in the setting of a melanoma screening clinic , 2007 .

[48]  C. Lebbé,et al.  A French CDK4-positive melanoma family with a co-inherited EDNRB mutation. , 2007, Journal of dermatological science.

[49]  Paolo Carli,et al.  Addition of dermoscopy to conventional naked-eye examination in melanoma screening: a randomized study. , 2004, Journal of the American Academy of Dermatology.

[50]  D. Hole,et al.  Incidence and thickness of primary tumours and survival of patients with cutaneous malignant melanoma in relation to socioeconomic status , 1996, BMJ.

[51]  K. Magnus,et al.  Trends in Cancer Incidence: Causes and Practical Implications , 1981 .

[52]  E. Bastiaannet,et al.  No increase of melanoma after kidney transplantation in the northern part of The Netherlands , 2007, Melanoma research.

[53]  R. MacKie,et al.  Hormone replacement therapy after surgery for stage 1 or 2 cutaneous melanoma , 2004, British Journal of Cancer.

[54]  N. Hayward,et al.  Melanocytic nevi, solar keratoses, and divergent pathways to cutaneous melanoma. , 2003, Journal of the National Cancer Institute.

[55]  M. Rademaker,et al.  Extremely high levels of melanoma in Tauranga, New Zealand: Possible causes and comparisons with Australia and the northern hemisphere , 2007, The Australasian journal of dermatology.